Last Updated 08:00:00
longbridge loading
Company Encyclopedia
name
SINOPHARM
01099.HK
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics.
139.65 B
01099.HKMarket value -Rank by Market Cap -/-
Daily Events
  1. Jun12

    Sinopharm (1099.HK) advanced 1.2% to close at HKD17.00 today, though intraday dynamics revealed market divergence: early selling pressure driven by profit-taking pushed the stock to intraday low HKD16…

  2. Jun11
    HK$17.000▲ 1.19%at close

    Sinopharm closed at HKD 16.80 today, down approximately 1.2%, pressured by broad weakness across Hong Kong equities. Q1 2026 operating revenue reached HKD 159.6 billion, up 5.19% year-over-year, thoug…

  3. Jun10
    HK$16.800▼ 1.64%at close

    China Pharma Holdings rebounded from its 52-week low of HK$16.43, closing at HK$17.08 with a modest daily gain of 0.11%, signaling cautious recovery after a steep year-to-date decline of 13.43%. Intra…

  4. Jun9
    HK$17.080▲ 1.12%at close

    Sinopharm fell 1.1% to HK$16.89 amid broader market weakness—the Hang Seng Index opened down 105 points—though morning rallies to HK$16.91 and an afternoon peak of HK$16.99 at 2:24 PM (Beijing time) f…

  5. Jun8
    HK$16.890▼ 1.11%at close

    Sinopharm Holdings softened to HK$17.08 today, a 0.76% decline from yesterday's close, primarily driven by profit-taking pressure in an ultra-low valuation zone after year-to-date losses of 13.43%. Th…

Financial Score

14/06/2026 Update
C
Health Care DistributorsIndustry
Industry Ranking5/22
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE8.57%B
    • Profit Margin1.24%C
    • Gross Margin6.65%E
  • Growth ScoreC
    • Revenue YoY1.90%C
    • Net Profit YoY3.09%C
    • Total Assets YoY2.23%C
    • Net Assets YoY11.87%B
  • Cash ScoreB
    • Cash Flow Margin228.43%B
    • OCF YoY1.90%C
  • Operating ScoreA
    • Turnover1.41A
  • Debt ScoreD
    • Gearing Ratio65.95%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --